click below
click below
Normal Size Small Size show me how
Unit 5 Cholesterol
LCC NURS 200 unit 5 Cholesterol Drugs
| Question | Answer |
|---|---|
| Antiplatelet Drugs Prototype | Asprin |
| Antiplatelet Drugs MOA | Block receptor sites on platelet membrane. |
| Antiplatelet Drug Indications | Patients at risk for thromboembolic events (stroke, MI) |
| Antiplatelet Drug Adverse Effects | Bleeding, GI distress, headache, dizziness, weakness. |
| Anticoagulant Prototype | Heparin, enoxaparin (Lovenox), dalteparin (Fragmin), warfarin (Coumadin) |
| Anticoagulants Indications | Prevents clots from forming/existing clots from growing in patients with thrombo-embolic event risk factors. |
| Anticoagulants Adverse Effects | Bleeding, Thrombocytopenia, nausea, vomiting, abdominal cramps. |
| Anticoagulants Contraindications/Cautions | Any condition that oculd be worsened by increased bleeding tendency. |
| Anticoagulants Interaction | Warfarin has MANY, Nitroglycerine decreases effect of Heparin. |
| Heparin Nursing Implications | Monitor effects of heparin by activated partial thromboplastin times (APTT or PTT), parenteral only, short half-life, |
| Heparin antidote prototype | protamine sulfate |
| Low-molecular weight heparins nursing implications | Somewhat safer and more predictable response, don’t require frequent lab monitoring, given subQ – not oral or IV. |
| Warfarin (Coumadin) Nursing Implications | given orally only, several days to achieve therapeutic levels, monitored by prothrombine time (PT) and INR. |
| Warfarin (Coumadin) antidote prototype | Vitamin K |
| Thrombolytic Agent Prototype | streptokinase (Streptase, Kabikinase) |
| Thrombolytic Agent MOA | convert plasminogen to plasmin wich breaks down fibrin threads in clots. |
| Thrombolytic Indcations | Acute MI, Stroke and pulmonary embolus |
| Thrombolytic Adverse Effects | Bleeding, Allergy/anaphylaxis |
| Thrombolytic Contraindications/Cautions | Any condition where clotting is desirable (recent surgery, trauma, active bleeding). |
| Thrombolytic Interactions | Other anticoagulants/antiplatelet meds must be closely monitored. |